Sentences with phrase «drug against leukemia»

Researchers report a surprising mechanism through which an important new candidate drug against leukemia exerts its therapeutic effect...

Not exact matches

Already one epigenetic drug, 5 - azacytidine, has been approved by the Food and Drug Administration for use against myelodysplastic syndrome, also known as preleukemia or smoldering leukedrug, 5 - azacytidine, has been approved by the Food and Drug Administration for use against myelodysplastic syndrome, also known as preleukemia or smoldering leukeDrug Administration for use against myelodysplastic syndrome, also known as preleukemia or smoldering leukemia.

So if researchers think that an individual drug for, say, chronic myeloid leukemia might work against a different kind of tumor because the two illnesses share similar biological underpinnings, they have to conduct a whole new clinical trial and go through the approval process all over again for the second condition.

Wapner's narrative follows developments from the recognition of a chromosomal abnormality in cancer cells to the production of a targeted drug against what had been a lethal leukemia.

Co-senior study investigator and cancer biologist Iannis Aifantis, PhD, says the study offers the first evidence that «drugs targeting and disrupting leukemia cells» microenvironment — or what goes on around them — could prove effective against the disease.»

A class of therapeutic drugs known as protein kinase inhibitors has in the past decade become a powerful weapon in the fight against various life - threatening diseases, including certain types of leukemia, lung cancer, kidney cancer and squamous cell cancer of the head and neck.

The drug imatinib mesylate (Gleevec) is shown to be effective against chronic myelogenous leukemia (CML).

Researchers at the University of Michigan Comprehensive Cancer Center have developed a new drug candidate that shows potential in laboratory studies against a rare type of acute leukemia.

This new therapy works well against B - cell acute lymphomblastic leukemia, a cancer of the blood system, which has led the U.S. Food and Drug Administration to expedite approval of the first CAR - T treatment for children and young adults.

Researchers at SciLifeLab has together with research physicians at Karolinska University Hospital and scientists at Heidelberg University identified a key player determining response to cytarabine — the most important drug against acute myelogenous leukemia.

The drug Gleevec, which has been touted in some circles as a miraculous silver bullet against some forms of leukemia, can still fail in patients who develop mutations that cause the drug to lose...